Carbohydrate Polymers in Cancer Treatment
The Scop of Special Issue:
This Special Issue covers Detection, Diagnosis, Imaging, Sensing and Treatment of cancer based on CPs-based biomaterials, where various active functional groups of CPs interact with the target enzyme. It also deals with the solubility and reactivity of functional groups, which facilitate the drug delivery and immune response. Moreover, the effect of the polarity of functional groups of CPs on the anti-cancer activity lies in the scope of this Special Issue. The molecular mechanisms underlying cancerous cell mortality caused by CPs, such as apoptosis and cell cycle arrest will also be included in topics of this Special Issue. In a more detailed view, some aspects can be outlined, as followings:
Cancer Diagnosis: Although screening and other approaches have been frequently applied for cancer diagnosis, most of the cancer patients are diagnosed in advanced/late stages, challenging the efficacy of current therapeutics. It has been shown that the introduction of CPs can facilitate cancer diagnosis by detection of circulating tumor cells and identification of cancer biomarkers.
Guest editor:
Prof. Mohammad Reza Saeb,
Department of Pharmaceutical Chemistry, Medical University of Gdańsk, Poland.
Manuscript submission information:
Manuscripts should be submitted online at https://www.editorialmanager.com/ijbiomac/default.aspx
Please select “VSI: Carbohydrate Polymers” when submitting your manuscript to this special issue and indicate the actual article type in the cover letter.
Deadline for manuscript submission: 30 March 2025.
Keywords:
Carbohydrate Polymers
Cancer Treatment
Polysaccharides
Chitosan
Agarose
Oncology
Tissue Engineering
Biomedical Engineering
International Journal of Biological Macromolecules的CAR指数
2023年3月份科睿唯安官方一次性踢除35本SCI期刊，多数涉及学术诚信问题，让我们意识到学术期刊的“被踢”指数，也很重要。目前，对于期刊的“被踢”指数，这里介绍一下：CAR指数（关于CAR的详细介绍，请关注：www.jcarindex.com），这是一种评价期刊学术诚信风险的指数，指数越高代表可能的风险越大。从数据看，International Journal of Biological Macromolecules不管是2022年度，还是2023年度的CAR指数，都是比较低的。当然，CAR指数仅供参考，期刊风险情况，需以科睿唯安或中科院预警等官方为准！
让推送更美好~
